Advancements in Lutetium-PSMA Therapy for Prostate Cancer: Clinical Trials and Future Directions – Ken Herrmann

Oliver Sartor and Ken Herrmann discuss the current state and future directions of PSMA ligand therapy in prostate cancer treatment. Dr. Herrmann presents recent findings from various clinical trials, including PSMAfore and ENZA-p, which explore the use of lutetium-PSMA therapy in different stages of prostate cancer. They examine the potential of combining lutetium-PSMA with other treatments like…

Read the full article here

Source: www.urotoday.com

Categories: General News, General Medicine News

Tags: ProstateCancer

Tweets with this article

UroToday.com

Advancements in lutetium-PSMA therapy for #ProstateCancer: Clinical trials and future directions. @ProfKHerrmann joins Oliver Sartor, MD @MayoClinic to discuss the current state and future directions of PSMA ligand therapy in prostate cancer treatment > https://t.co/DyFRaify05 https://t.co/UJHUytupGL

Case-Based Discussion on Navigating the Evolving Landscape of Castrate-Resistant Prostate Cancer Management – Oliver Sartor

Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: A.…

UroToday.com February 7, 2025

Real-World Evidence Informs Clinical Decision-Making in Metastatic Castration-Resistant Prostate Cancer – Alan Bryce

UroToday.com February 7, 2025

Pharmalittle: We’re reading about a Hims Super Bowl ad, USAID freeze hurting clinical trial patients, and more

Lawmakers want the FDA to review whether a Super Bowl ad from Hims & Hers runs afoul of pharmaceutical advertising rules

pharmalot February 7, 2025

An Overview of Strategies and Therapeutic Advances in Metastatic Prostate Cancer – Rana McKay

UroToday.com February 7, 2025

Dr David Dunstan – Physical Activity | Sedentary Behaviour | Diabetes | Physical Activity Researcher

In this episode, we have Professor David Dunstan from the Baker Heart and Diabetes Institute in Melbourne. His research focuses on the role of physical…

Physical Activity Researcher Podcast 🎙️ February 7, 2025

Event Scholarship Application

STAT Breakthrough Summit East | March 20, 2025 We’re committed to making STAT events accessible to as many attendees as possible. Our event scholarship

STAT February 6, 2025

SWOG Trial On Standard vs Extended Lymphadenectomy in Muscle Invasive Bladder Cancer – Seth Lerner

Seth Lerner discusses the SWOG study on standard versus extended lymphadenectomy for muscle-invasive bladder cancer published October 2024 in the New England Journal of Medicine.…

UroToday.com February 6, 2025

Para trabajadores agrícolas de California, las consultas con médicos mexicanos a distancia llenan un vacío – KFF Health News

Este método, que podría llegar a tener gran utilidad en la era de los teléfonos inteligentes, es una aplicación que permite efectuar consultas médicas transfronterizas.

Kaiser Health News February 6, 2025

Epigenetic Profiling Identifies Biomarkers Predicting Resistance to AR-Targeted Therapy in mCRPC – Wilbert Zwart

Wilbert Zwart joins Neeraj Agarwal to discuss research on epigenetic targeting in prostate cancer. The discussion examines histone markers in metastatic castration-resistant prostate cancer (mCRPC)…

UroToday.com February 6, 2025

Sexual Dysfunction After Radical Cystectomy – Trinity Bivalacqua

Zachary Klaassen and Trinity Bivalacqua discuss sexual dysfunction following radical cystectomy, highlighting significant disparities in how these issues are addressed between male and female patients.…

UroToday.com February 6, 2025

Related Articles